1Department of Neurosurgery, University of Virginia, Charlottesville, Virginia.
2Department of Neurosurgery, University of Pittsburgh.
J Neurosurg. 2018 Aug;129(2):498-507. doi: 10.3171/2017.3.JNS162635. Epub 2017 Sep 8.
OBJECTIVE Due to the complexity of Spetzler-Martin (SM) Grade IV-V arteriovenous malformations (AVMs), the management of these lesions remains controversial. The aims of this multicenter, retrospective cohort study were to evaluate the outcomes after single-session stereotactic radiosurgery (SRS) for SM Grade IV-V AVMs and determine predictive factors. METHODS The authors retrospectively pooled data from 233 patients (mean age 33 years) with SM Grade IV (94.4%) or V AVMs (5.6%) treated with single-session SRS at 8 participating centers in the International Gamma Knife Research Foundation. Pre-SRS embolization was performed in 71 AVMs (30.5%). The mean nidus volume, SRS margin dose, and follow-up duration were 9.7 cm, 17.3 Gy, and 84.5 months, respectively. Statistical analyses were performed to identify factors associated with post-SRS outcomes. RESULTS At a mean follow-up interval of 84.5 months, favorable outcome was defined as AVM obliteration, no post-SRS hemorrhage, and no permanently symptomatic radiation-induced changes (RIC) and was achieved in 26.2% of patients. The actuarial obliteration rates at 3, 7, 10, and 12 years were 15%, 34%, 37%, and 42%, respectively. The annual post-SRS hemorrhage rate was 3.0%. Symptomatic and permanent RIC occurred in 10.7% and 4% of the patients, respectively. Only larger AVM diameter (p = 0.04) was found to be an independent predictor of unfavorable outcome in the multivariate logistic regression analysis. The rate of favorable outcome was significantly lower for unruptured SM Grade IV-V AVMs compared with ruptured ones (p = 0.042). Prior embolization was a negative independent predictor of AVM obliteration (p = 0.024) and radiologically evident RIC (p = 0.05) in the respective multivariate analyses. CONCLUSIONS In this multi-institutional study, single-session SRS had limited efficacy in the management of SM Grade IV-V AVMs. Favorable outcome was only achieved in a minority of unruptured SM Grade IV-V AVMs, which supports less frequent utilization of SRS for the management of these lesions. A volume-staged SRS approach for large AVMs represents an alternative approach for high-grade AVMs, but it requires further investigation.
由于 Spetzler-Martin(SM)分级 IV-V 动静脉畸形(AVM)的复杂性,这些病变的治疗仍然存在争议。本多中心回顾性队列研究的目的是评估单次立体定向放射外科(SRS)治疗 SM 分级 IV-V AVM 的结果,并确定预测因素。
作者回顾性地汇总了 233 名患者(平均年龄 33 岁)的数据,这些患者在国际伽玛刀研究基金会的 8 个参与中心接受了单次 SRS 治疗,SM 分级为 IV(94.4%)或 V AVM(5.6%)。71 个 AVM 进行了术前栓塞(30.5%)。平均病灶体积、SRS 边缘剂量和随访时间分别为 9.7cm、17.3Gy 和 84.5 个月。进行了统计学分析,以确定与 SRS 后结果相关的因素。
在平均 84.5 个月的随访中,将 AVM 闭塞、无 SRS 后出血和无永久性症状性放射性诱导改变(RIC)定义为良好结果,26.2%的患者达到了这一结果。3、7、10 和 12 年的累积闭塞率分别为 15%、34%、37%和 42%。SRS 后每年出血率为 3.0%。10.7%和 4%的患者分别出现症状性和永久性 RIC。多变量逻辑回归分析显示,只有较大的 AVM 直径(p=0.04)是不良结果的独立预测因素。未破裂的 SM 分级 IV-V AVM 与破裂的 AVM 相比,良好结果的发生率显著降低(p=0.042)。在各自的多变量分析中,术前栓塞是 AVM 闭塞(p=0.024)和放射学明显 RIC(p=0.05)的阴性独立预测因素。
在这项多机构研究中,单次 SRS 治疗 SM 分级 IV-V AVM 的效果有限。只有少数未破裂的 SM 分级 IV-V AVM 获得了良好的结果,这支持对这些病变更不频繁地使用 SRS 治疗。对于大型 AVM,采用分阶段 SRS 治疗是一种替代方法,但需要进一步研究。